Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
EVOLUTION AT MERCK - INVENTING FOR LIFE slide image

EVOLUTION AT MERCK - INVENTING FOR LIFE

ONCOLOGY: POTENTIAL FOR >50 ADDITIONAL INDICATIONS OVER NEXT 5 YEARS Proportion of expected indications by product Lynparza olaparib tablets 150 mg KEYTRUDA (pembrolizumab) Injection 100 mg LENVIMA (lenvatinib) capsules 10 mg and 4 mg Potential to nearly triple oncology indications by 2023 MERCK # Frank Clyburn INVENTING FOR LIFE 23
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube